Fig. 01 -

Title Slide

Fig. 02 -

Disclosures

Fig. 03 -

Why

Fig. 04 -

Overview

Fig. 05 -

BCG Failure

Fig. 06 -

Heterogeneous

Fig. 07 -

Subtypes

Fig. 08 -

Clusters

Fig. 09 -

AUA/SUO

Fig. 10 -

2016 Guideline

Fig. 11 -

BCG vs Cystectomy

Fig. 12 -

Maintenance

Fig. 13 -

ProlongsSurvival

Fig. 14 -

Recurrence-free

Fig. 15 -

Not Created Equal

Fig. 16 -

Papillary Recurrence

Fig. 17 -

Progression-Free vs Disease-Specific

Fig. 18 -

EORTC 30962

Fig. 19 -

Decision Timing

Fig. 20 -

Salvaged Failures

Fig. 21 -

Failure Definition

Fig. 22 -

Review Article

Fig. 23 -

BCG Unresponsive

Fig. 24 -

BC Group Definition

Fig. 25 -

BCG/Interferon

Fig. 26 -

Cancer in situ

Fig. 27 -

Papillary Tumor

Fig. 28 -

Recurrent CIS

Fig. 29 -

Hyperthermic Mitomycin

Fig. 30 -

BCG-unresponsive

Fig. 31 -

Phase 2

Fig. 32 -

Comprehensive Transcriptional Analysis

Fig. 33 -

Progression Events

Fig. 34 -

International BC Group

Fig. 35 -

BCG after TUR

Fig. 36 -

Recurrence

Fig. 37 -

Thank You